Thomas Leggett, Chief Financial Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 3,000 shares at $33.53 ($101K) on 2020-10-08, disclosed to the SEC on 2020-10-09.
Open-market sale of $101k BDTX by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BDTX | SELL | 2020-12-10 | $167K | — | Filing → |
| BDTX | SELL | 2020-11-12 | $99K | — | Filing → |
| BDTX | SELL | 2020-09-16 | $93K | — | Filing → |